Skip to main content
Equibles

Eversept Partners, LP

Position in IFRX — InflaRx N.V.

CIK 1697013 NEW YORK, NY
Back to IFRX Full portfolio

Position in IFRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,921,114
+$1,348,950 QoQ
Shares Held
1,304,069
-25.8% QoQ
Ownership
0.885%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#15
of 62 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IFRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Eversept Partners, LP holds $859,319,346 across 72 Biotechnology names. IFRX ranks #42 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ABVX
Abivax S.A.
 913,880 $121,783,648
2 VERA
Vera Therapeutics, Inc.
 2,212,770 $94,949,960
3 CLDX
Celldex Therapeutics, Inc.
 1,785,941 $66,454,864
4 SNDX
Syndax Pharmaceuticals Inc
 2,798,210 $61,168,870
5 IONS
Ionis Pharmaceuticals Inc
 664,684 $52,702,794
6 TVTX
Travere Therapeutics, Inc.
 798,973 $45,389,656
7 PCVX
Vaxcyte, Inc.
 629,952 $36,619,109
8 GERN
Geron Corp
 18,717,422 $23,958,300

All Filings in IFRX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,921,114 1,304,069
2026-03-31 $1,572,164 1,758,573
2025-12-31 $1,774,885 1,757,312
2025-09-30 $2,319,050 1,730,635
2025-06-30 $1,295,939 1,640,430
2025-03-31 $1,709,497 1,675,978
2024-12-31 $1,216,356 492,452
2024-09-30 $2,481,334 1,621,787
2024-06-30 $2,726,458 1,566,930
2024-03-31 $2,009,915 1,305,140
2023-12-31 $2,127,378 1,305,140
2023-09-30 $5,177,881 1,737,544
2023-06-30 $8,541,403 1,915,113
2021-03-31 $1,047,672 268,634
2020-03-31 $746,764 195,488